Provided by Tiger Trade Technology Pte. Ltd.

SciSparc Ltd.

5.83
-0.8000-12.07%
Volume:87.03K
Turnover:504.43K
Market Cap:3.39M
PE:-0.06
High:6.22
Open:6.06
Low:5.50
Close:6.63
52wk High:80.10
52wk Low:2.98
Shares:581.00K
Float Shares:561.10K
Volume Ratio:2.58
T/O Rate:15.51%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-98.0714
EPS(LYR):-98.0714
ROE:-178.39%
ROA:-60.68%
PB:0.80
PE(LYR):-0.06

Loading ...

BRIEF-Scisparc Neurothera Labs- Clearmind Medicine Collaboration Leads To Patent Application For Depression Therapy

Reuters
·
Mar 16

NeuroThera Labs files Hong Kong patent application for MEAI-PEA depression therapy

Reuters
·
Mar 16

Scisparc: Neurothera Labs- Clearmind Medicine Collaboration Leads to Patent Application for Depression Therapy

THOMSON REUTERS
·
Mar 16

Clearmind Medicine Announces Hong Kong Patent Filing for Depression Therapy

THOMSON REUTERS
·
Mar 13

BUZZ-U.S. STOCKS ON THE MOVE -Natera, Pacira BioSciences, Kezar Life Sciences

Reuters
·
Mar 12

BUZZ-SciSparc jumps as unit files patent for obesity, fatty liver treatment

Reuters
·
Mar 12

SciSparc-Controlled NeuroThera Labs Publishes PCT Patent for MEAI-PEA Weight Loss and MASLD Therapy

Reuters
·
Mar 12

Scisparc: Neurothera Labs Announces Publication of International Patent in Collaboration With Clearmind Medicine for Novel Therapy Targeting Weight Loss and Fatty Liver Disease

THOMSON REUTERS
·
Mar 12

SciSparc says Neurothera Labs agrees to acquire majority stake in CliniQuantum

TIPRANKS
·
Mar 10

Scisparc Ltd - Neurothera to Buy 56,375 Cliniquantum Shares Representing 54.01% Stake

THOMSON REUTERS
·
Mar 10

Scisparc Ltd - Selling Shareholders May Receive Earn-Out Payments up to $2.5 Mln

THOMSON REUTERS
·
Mar 10

Scisparc: Subsidiary Neurothera Labs (75%) Signs Definitive Agreement to Acquire Majority Stake in Cliniquantum, Innovator in Quantum-Based Clinical Trails

THOMSON REUTERS
·
Mar 10

Press Release: SciSparc: Subsidiary NeuroThera Labs (75%) Signs Definitive Agreement to Acquire Majority Stake in CliniQuantum, Innovator in Quantum-based Clinical trails

Dow Jones
·
Mar 10

Top Premarket Decliners

MT Newswires Live
·
Mar 10